Effects of Sacubitril/Allisartan versus Olmesartan on serum uric acid in Chinese patients with hypertension and hyperuricaemia
CardiologiaSobre o estudo
- Desenho
- Ensaio clínico randomizado
- Nível de evidência
- 2 · Nova evidência
- Revista
- Hypertension research : official journal of the Japanese Society of Hypertension
- Publicado em
- 20 abr 2026
- Citações
- 0
O resumo deste estudo é do publisher e não tem licença aberta: por isso mostramos aqui só os dados do estudo, e o texto fica na fonte original, nos links abaixo.
O estudo original
Effects of Sacubitril/Allisartan versus Olmesartan on serum uric acid in Chinese patients with hypertension and hyperuricaemia
Wei Zhang, Jie Yan, Jin Zhang, Qian Ge, Xiao-Hong Lu, Wen-Jie Xu, Jing-Chao Sun, Sheng-Mei Mu, Yan Chen, Zi-Chen Liu et al.
Descritores MeSH
- Imidazoles
- Aminobutyrates
- Antihypertensive Agents
- Tetrazoles
- Uric Acid
- Hypertension
- Hyperuricemia
- Angiotensin Receptor Antagonists
- East Asian People
- Male
Veja também
Estudos relacionados
- Blood pressure-lowering efficacy of Sacubitril/Allisartan versus Olmesartan in Chinese hypertensive patients with a nondipping blood pressure pattern
- Sacubitril/valsartan role in patients with resistant hypertension: a systematic review
- Comparison of sacubitril/valsartan with olmesartan for hypertension: A meta-analysis of randomized controlled trials
- Efficacy and Safety Comparative of Sacubitril/Valsartan vs. Olmesartan in the Treatment of hypertension: A Meta-analysis of RCTs